|
|
|
|
|
|
|
|
Board of Directors

Mats Grahn
Chairman of the Board
M.Sc. in Engineering Physics from Lund University. Former Corporate Vice President Marketing at Dako A/S. More than 20 years of experience from biotechnological and biopharmaceutical industry, both in marketing and R&D.
Carl Borrebaeck
Professor at the Department of Immunotechnology, Lund University.
Member of the Board of BioInvent International AB and Nordic Vaccine A/S.
Program Director of CREATE Health- Center for Translational Cancer Research.
Deputy vice-Chancellor for Innovations, Lund University.

Kenth Petersson
B.A. Partner in Science Pacific. Chairman of the Board of Spider Technologies AB, Alphabeta AB, Biocrine AB and Diabetes Tools Sweden AB
Member of the Board of BioInvent International AB and others.
Karl Olof Borg
Ph.D. in Pharmaceutical Sciences from Uppsala University.
Chairman of the Board of Bioinvent International AB. Member of the Board of Pharmexa A/S, Galenica AB, Biocrine AB and Eurocine Vaccine AB.

Paula Zeilon CEO acting. M. Sc. Chemistry, Lund University. Member of the Board of Biogaia AB (publ). Partner of Conlega Biobusiness Development and Management.
|
|
|
|
|
|
|
|
|
|
|